logo
Plus   Neg
Share
Email

EMA Accepts Astellas' Marketing Authorization Application For Roxadustat

Astellas Pharma Inc. and FibroGen Inc. (FGEN) said that the European Medicines Agency
has accepted the marketing authorization application for roxadustat for regulatory review. roxadustat is a drug for treatment of anemia in adult patients with chronic kidney disease.

EMA's acceptance of the roxadustat MAA for treatment of anemia in adult patients with chronic kidney disease on dialysis and not on dialysis triggers a milestone payment of $130 million by Astellas to FibroGen.

Chronic kidney disease is a progressive loss of kidney function caused by damage to the kidneys resulting from conditions such as hypertension, diabetes or immune-regulated inflammatory conditions.

Anemia is a common complication of CKD,resulting from the failing kidneys' diminished ability to produce erythropoietin, which stimulates red blood cell production in the bone marrow. It is associated with significant morbidity and mortality in dialysis and non-dialysis populations, increasing in both prevalence and severity as kidney disease worsens.

Anemia associated with CKD increases the risk of adverse cardiovascular events, worsens renal outcomes and can negatively impact patients' quality of life.

Roxadustat is approved and launched for the treatment of anemia associated with CKD in Japan in DD patients and in China in both DD and NDD patients. A supplemental New Drug Application has been submitted to Japan's Pharmaceuticals and Medical Devices Agency for NDD patients and a New Drug Application has been submitted in the US in both DD and NDD patients.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Retail giant Walmart announced that back-to-school essentials are available at its stores with easy, contact-free shopping options. The announcement comes as the Trump administration initiated a campaign to press state authorities to reopen schools for Fall semester, even as COVID-19 pandemic is spreading out of control in the United States. Schools across the country remain shut since March. Bed Bath & Beyond, Inc. is planning to close around 200 mostly Bed Bath & Beyond stores over the next two years amid continuing struggles with Covid-19. The home improvement retailer, which reported a wider-than-expected loss in its first quarter with sharply lower sales, said the move is part of its plans to right-size its real estate portfolio and to cut costs. United Airlines has warned that 36,000 employees or about 45% of its U.S. workforce could be furloughed in October, due to continuing losses caused by the coronavirus pandemic and collapse in air travel, according to reports citing the company's memo sent to employees.
RELATED NEWS
Follow RTT